Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Avantium still wants to make the plastic bottle of the future. The problem is that the future keeps needing more time, more commissioning work and more shareholder cash.
Avantium now expects commercial deliveries from its FDCA flagship plant in Delfzijl, the Netherlands, to begin at the end of this year.
The plant is designed to produce FDCA, the key building block for PEF, Avantium's plant-based and circular polymer marketed under the Releaf brand. Its technology converts plant-based sugars into FDCA, which can then be used to make PEF for bottles, packaging, fibers and specialty applications.
The company said the oxidation unit at the Delfzijl plant has been successfully commissioned, following the start-up of utility systems and the sugar dehydration unit. Commissioning work on the purification unit is being finalized.

#commissioning #based

Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Management attributed the 25% adjusted EBITDA growth and 260 basis point margin expansion to structural improvements rather than cyclical market recovery, which remains uneven.
The company achieved its $90 million run rate cost optimization milestone ahead of schedule by simplifying the organization and optimizing the manufacturing network.
Performance in Polymer Solutions was driven by IBC and large container strength, while Closures benefited from high single-digit volume growth through new business wins.
Management highlighted a strategic shift in the sales force from 'farmers' to 'hunters,' focusing on solution-based selling and new logo acquisition in high-value segments like pharma and fragrances.

#high #NVIDIA #polymer

Cardi B is clearing up speculation about her body after fans questioned whether she recently had her **** injections dissolved. During a candid Instagram Live, the Grammy-winning rapper addressed ongoing conversations about her appearance, revealing that she already underwent a **** ocks reduction procedure in January 2024 and has no plans to have additional surgery anytime soon.
The "I Like It" hitmaker, who has long been open about her cosmetic procedures, reminded fans that she's never hidden her plastic surgery journey. "A lot of y'all keep telling me to go get my a** reduced," Cardi said during the livestream. "I don't need to go get my a** reduced, news flash, I did get my a** reduced."
The "I Like It" hitmaker, who has long been open about her cosmetic procedures, reminded fans that she's never hidden her plastic surgery journey. (GC Images)
Cardi, 33, explained that while many people **** ume she recently changed her appearance, the procedure actually happened more than two years ago. According to the rapper, she had the silicone-based biopolymer injections she received in her early 20s "reduced" rather than completely removed.
You may also like

#cardi #reduced #surgery

Cardi B revealed she had her **** injections reduced over two years ago while addressing criticism about her body in a recent Instagram Live
The rapper shared that she had biopolymer injections at 21 but later reduced them due to her "small" frame
Cardi emphasized her healthy lifestyle and called out critics, saying she's comfortable with her current appearance
Cardi B is responding to claims that she had her **** injections dissolved.
When she was just 21 years old, the rapper received biopolymer injections, which are made from silicone-based fillers not approved by the FDA and can leak and cause other complications.

#biopolymer #revealed

Westlake Corp (NYSE: WLK) has been one of the top mid-cap stocks to own for decades, according to hedge funds. On June 15, Westlake Corp (NYSE:WLK) strengthened its Performance & Essential Materials business by completing the acquisition of a polyvinyl chloride and vinyl chloride monomer production site located in Wilhelmshaven, Germany.
The company completed the acquisition through its German subsidiary Westlake Vinnolit GmbH & Co. KG. The acquired polyvinyl chloride and vinyl chloride monomer production site has the potential to produce 380,000 metric tons of PVC per year, thereby expanding Westlake's global chlorovinyl manufacturing footprint.
The acquired production site's competitive edge stems from its advantageous logistical infrastructure, which includes a deep-water dock that enables efficient raw material supply. Consequently, it is expected to strengthen the company's chlorovinyl production facilities in Europe and North America.
Meanwhile, on July 1, Mizuho reiterated a Neutral rating on the stock but lowered its price target to $88 from $110. The price target cut comes on the research firm lowering price targets for most of its basic chemical targets as focus shifts to technology material stocks.
Westlake Corp (NYSE:WLK) is a global industrial company that manufactures basic petrochemicals, polymers, and building products. They produce the raw chemical building blocks used in everyday items, such as food packaging, medical devices (like IV bags), clean-water piping, and automotive components.

Chinese scientists have developed a new method to directly manufacture rubber and plastic from a mixture of hydrogen and carbon monoxide gases, an advance that could reduce industrial reliance on fossil fuels.
Olefins, or organic compounds, derived from petroleum are the building blocks for many polymers, including commonly used plastic and rubber products.
This has directly amplified the carbon footprint of the entire industry.
While alternatives exist – such as the use of a mixture of hydrogen and carbon monoxide gases called syngas from decomposing organic matter – these have been shown